bigger Created with Sketch.

Our mission is focused on curing disease and transforming patients’ lives

Learn About Our Technology

Our mission is focused on curing disease and transforming patients’ lives

Learn About Our Technology

Creating a Hopeful Reality

“This is powerful technology. It’s the iteration of over 100 years of work that has been done to define what a gene is and what it does, and now we can finally use that information to work to cure severe genetic disorders.”

Arthur Tzianabos, Ph.D.
Chief Executive Officer

Leaders in Genetic
Medicines

Homology Medicines has a broad, powerful and proprietary gene editing and gene therapy platform, an experienced and dedicated team and a commitment to bring new treatments and cures forward for the rare disease community.

Meet our Team

Recent News

07/21/2020
Homology Medicines Appoints Jeff Poulton to the Board of Directors​
05/26/2020
Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program​
05/12/2020
Homology Medicines Announces Presentations on its In Vivo Gene Therapy and Gene Editing Programs and Commercial Manufacturing Platform at the American Society of Gene & Cell Therapy Annual Meeting​
VIEW ALL NEWS

“We have the opportunity now not just to treat patients but to potentially cure them.”

Albert Seymour, Ph.D.
Chief Scientific Officer